Similarly, no significant differences in anti-MOG autoantibody levels were found in the peripheral blood between the healthy controls (0.27 ± 1.25 ng/mL), the white matter lesion control group (0.2 ± 0.45 ng/mL), and the patients with MS (0.25 ± 1.13 ng/mL) (Figure 3A). The gene discussed is MOG; the disease is myeloid sarcoma.